Chief Financial Officer
Chief Financial Officer at Kymera Therapeutics, Inc., filing insider transactions between 2026-03-02 and 2026-06-30.
| SEC ↗ |
| 2026-06-30 | KYMR | Sale | 1,700 | $111.57 | $190K | SEC ↗ |
| 2026-06-30 | KYMR | Sale | 3,200 | $117.70 | $377K | SEC ↗ |
| 2026-06-30 | KYMR | Sale | 4,110 | $114.19 | $469K | SEC ↗ |
| 2026-06-30 | KYMR | Sale | 51.4K | $114.77 | $5.9M | SEC ↗ |
| 2026-06-30 | KYMR | Sale | 6,153 | $116.99 | $720K | SEC ↗ |
| 2026-03-04 | KYMR | Sale | 2,519 | $85.04 | $214K | SEC ↗ |
| 2026-03-04 | KYMR | Sale | 1,437 | $85.78 | $123K | SEC ↗ |
| 2026-03-04 | KYMR | Sale | 447 | $86.62 | $39K | SEC ↗ |
| 2026-03-04 | KYMR | Sale | 492 | $84.00 | $41K | SEC ↗ |
| 2026-03-02 | KYMR | Sale | 4,113 | $89.66 | $369K | SEC ↗ |
| 2026-03-02 | KYMR | Sale | 1,424 | $88.50 | $126K | SEC ↗ |
| 2026-03-02 | KYMR | Sale | 2,039 | $87.75 | $179K | SEC ↗ |